Relative Bioavailability and Food Effect for Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination

NCT02475135 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide FDC
DRUG: Elvitegravir /Cobicistat/Emtricitabine/Tenofovir alafenamide FDC
DRUG: Darunavir
DRUG: Emtricitabine/Tenofovir alafenamide (FTC/TAF)
DRUG: Cobicistat
OTHER: High-fat Breakfast
OTHER: Standardized Regular Breakfast

Sponsor

Janssen Sciences Ireland UC